Table 1 |
||||||||
|
Frequency of restriction enzyme sites in HIV |
||||||||
| Type |
Group |
Subtype |
N |
NotI |
MluI |
SbfI |
FseI |
AsiSI |
|
|
||||||||
| HIV-1 |
M |
A |
86 |
0 |
0 |
7 |
0 |
0 |
| B |
211 |
17 |
4 |
99 |
0 |
0 |
||
| C |
425 |
8 |
3 |
95 |
0 |
0 |
||
| D |
61 |
0 |
1 |
46 |
0 |
0 |
||
| A/E |
92 |
0 |
1 |
49 |
0 |
0 |
||
| F |
20 |
0 |
2 |
12 |
0 |
0 |
||
| G |
130 |
0 |
3 |
10 |
0 |
0 |
||
| H |
100 |
0 |
1 |
3 |
0 |
0 |
||
| J |
73 |
0 |
0 |
1 |
0 |
0 |
||
| K |
23 |
0 |
0 |
13 |
0 |
0 |
||
| N |
29 |
0 |
0 |
2 |
0 |
0 |
||
| O |
143 |
0 |
3 |
30 |
0 |
0 |
||
| HIV-2 |
18 |
1 |
1 |
2 |
0 |
0 |
||
|
|
||||||||
|
N = Number of sequences analyzed. |
||||||||
|
Dash et al. Retrovirology 2008 5:25 doi:10.1186/1742-4690-5-25 |
||||||||
